|
 | about Bupa | press releases
Better cover for cancer patients
19 July 2006
Bupa’s cancer cover has just got even better as the health insurer announced the removal of benefit limits for out-patient cancer treatments.
The change, which applies to annual monetary out-patient benefit limits for eligible treatment on the majority of Bupa’s schemes, comes into force immediately.
Dr Paula Franklin, Bupa Health Insurance deputy medical director, said: “This change is driven by our desire to continue to provide extensive cover for cancer patients and give them access to high quality cancer care. In its report about private medical insurance cover for cancer, leading cancer information charity Cancerbackup highlighted the fact that Bupa is the only insurer to provide cover for patients at every stage of their cancer.”
Bupa is also the only insurer to have accredited networks of specialist treatment centres for breast, bowel and gynaecological cancers. This means that our members can receive treatment as early as possible at the right place and delivered by an expert specialist team. All of this gives them the best possible chance of recovery.
For reassurance and support, members are also able to talk to one of our specialist oncology nurses at any time during their treatment.
By undertaking rigorous evidence-based evaluation of new treatments, Bupa funds drugs for early stage breast, bowel and lung cancers, like Herceptin, even when such drugs are not available from the NHS or not funded by some of our competitors. In 2005 over 60,000 members benefited from Bupa-covered cancer treatments.
Bupa covers all eligible hospital and consultant charges for chemotherapy, chemotherapy drugs, radiotherapy and surgery. Bupa members can also, with the agreement of their consultant, receive certain cancer treatments in the comfort of their own home via Bupa’s agreement with ‘Healthcare at Home’, the UK’s leading home healthcare provider.
|
